Shaun Noorian

So to talk about peptides and the conspiracy theories, I've heard them all. And if you look at what the state and federal agencies are doing, all they're doing is the same thing they've always done, enforcing the rules and regulations that are currently in place. And so it's just a coincidence that peptides,

So to talk about peptides and the conspiracy theories, I've heard them all. And if you look at what the state and federal agencies are doing, all they're doing is the same thing they've always done, enforcing the rules and regulations that are currently in place. And so it's just a coincidence that peptides,

FDA is starting to put more attention to these peptides that weren't allowed to be made in the first place at the same time as semaglutide and terzapatide and other GLP-1s have been on backwater. It's really just about making sure that our drug supply chain utilizes drugs from regulated industries that are listed within that the FDA and state boards allow you to make.

FDA is starting to put more attention to these peptides that weren't allowed to be made in the first place at the same time as semaglutide and terzapatide and other GLP-1s have been on backwater. It's really just about making sure that our drug supply chain utilizes drugs from regulated industries that are listed within that the FDA and state boards allow you to make.

FDA is starting to put more attention to these peptides that weren't allowed to be made in the first place at the same time as semaglutide and terzapatide and other GLP-1s have been on backwater. It's really just about making sure that our drug supply chain utilizes drugs from regulated industries that are listed within that the FDA and state boards allow you to make.

Now, when we talk about other peptides like the GLP-1s, You know, company pharmacies have really stepped in and made a huge difference where there is a national and global shortage where Eli Lilly and Novo Nordisk, the makers of Wegovu, Wegovi, Ozembic, Zepound, and Mangiorno, the brand names for semaglutide and terzapatide, can't keep up with demand.

Now, when we talk about other peptides like the GLP-1s, You know, company pharmacies have really stepped in and made a huge difference where there is a national and global shortage where Eli Lilly and Novo Nordisk, the makers of Wegovu, Wegovi, Ozembic, Zepound, and Mangiorno, the brand names for semaglutide and terzapatide, can't keep up with demand.

Now, when we talk about other peptides like the GLP-1s, You know, company pharmacies have really stepped in and made a huge difference where there is a national and global shortage where Eli Lilly and Novo Nordisk, the makers of Wegovu, Wegovi, Ozembic, Zepound, and Mangiorno, the brand names for semaglutide and terzapatide, can't keep up with demand.

And during times where a drug is on shortage, the only other legal avenue for patients and prescribers to get access to these medications are through compounding pharmacies and outsourcing facilities. And that's one of the reasons why we exist, to be able to add additional supply to our country's supply chain during times of need.

And during times where a drug is on shortage, the only other legal avenue for patients and prescribers to get access to these medications are through compounding pharmacies and outsourcing facilities. And that's one of the reasons why we exist, to be able to add additional supply to our country's supply chain during times of need.

And during times where a drug is on shortage, the only other legal avenue for patients and prescribers to get access to these medications are through compounding pharmacies and outsourcing facilities. And that's one of the reasons why we exist, to be able to add additional supply to our country's supply chain during times of need.

Now, these drugs, yes, we pay a lot more for them in the United States than we pay anybody else.

Now, these drugs, yes, we pay a lot more for them in the United States than we pay anybody else.

Now, these drugs, yes, we pay a lot more for them in the United States than we pay anybody else.

It's a good question. Because a lot of patients and prescribers, it's... They think that compounding pharmacies and outsourcing facilities, we get our active pharmaceutical ingredients off the street.

It's a good question. Because a lot of patients and prescribers, it's... They think that compounding pharmacies and outsourcing facilities, we get our active pharmaceutical ingredients off the street.

It's a good question. Because a lot of patients and prescribers, it's... They think that compounding pharmacies and outsourcing facilities, we get our active pharmaceutical ingredients off the street.

Nothing is further from the truth. We have to source, by law, we have to source our ingredients from the same exact places that pharma sources them from, FDA-registered active pharmaceutical ingredient manufacturing facilities. And so we get the same.

Nothing is further from the truth. We have to source, by law, we have to source our ingredients from the same exact places that pharma sources them from, FDA-registered active pharmaceutical ingredient manufacturing facilities. And so we get the same.

Nothing is further from the truth. We have to source, by law, we have to source our ingredients from the same exact places that pharma sources them from, FDA-registered active pharmaceutical ingredient manufacturing facilities. And so we get the same.